Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2323]
News [5452]
Articles [134]
Editorials [4]
Conferences [158]
elearning [13]
Tailoring treatment strategies in prostate cancer: expert insight
Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu
Tailoring treatment strategies in prostate cancer: expert insight ( Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu )
26 Sep 2015
Circulating levels of tumour DNA in plasma may help monitor treatment response...
Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL ( Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia )
10 Sep 2015
Cytogenetic and proteomic prognostic markers of CLL
Dr Lauren Thurgood - Flinders University, Adelaide, South Australia
Cytogenetic and proteomic prognostic markers of CLL ( Dr Lauren Thurgood - Flinders University, Adelaide, South Australia )
9 Sep 2015
Predicting progression and survival in CLL
Prof Jonathan Strefford - University of Southampton, Southampton, UK
Predicting progression and survival in CLL ( Prof Jonathan Strefford - University of Southampton, Southampton, UK )
9 Sep 2015
Expert panel discussion: The best of iwCLL 2015
Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai
Expert panel discussion: The best of iwCLL 2015 ( Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai )
9 Sep 2015
Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells
Dr Alexey Danilov - Oregon Health and Science University, Portland, USA
Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells ( Dr Alexey Danilov - Oregon Health and Science University, Portland, USA )
9 Sep 2015
High remission rates for new CLL treatment
Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia
High remission rates for new CLL treatment ( Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia )
9 Sep 2015
CLL from a patient and physician perspective
Dr Brian Koffman MD – Medical Director of the CLL Society
CLL from a patient and physician perspective ( Dr Brian Koffman MD – Medical Director of the CLL Society )
9 Sep 2015
Harmonisation of CLL diagnosis and detection of residual disease monitoring by...
Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK
Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry ( Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK )
8 Sep 2015
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi...
Dr Amy Johnson – The Ohio State University, Columbus, USA
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )
8 Sep 2015
Results of a new phase Ib trial of voxtalisib in combination with...
Prof Farrukh Awan - Ohio State University, Columbus, USA
Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )
8 Sep 2015
A laboratory model of the hypoxic tumour microenvironment
Dr Giles Best - Royal North Shore Hospital, Sydney, Australia
A laboratory model of the hypoxic tumour microenvironment ( Dr Giles Best - Royal North Shore Hospital, Sydney, Australia )
8 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation